Eichler April F, Loeffler Jay S
Pappas Center for Neuro-Oncology, Massachusetts General Hospital, Boston, MA 02114, USA.
Oncologist. 2007 Jul;12(7):884-98. doi: 10.1634/theoncologist.12-7-884.
Metastatic brain tumors are the most common intracranial neoplasms in adults. The incidence of brain metastases appears to be rising as a result of superior imaging modalities, earlier detection, and more effective treatment of systemic disease. Therapeutic approaches to brain metastases include surgery, whole brain radiotherapy (WBRT), stereotactic radiosurgery (SRS), and chemotherapy. Treatment decisions must take into account clinical prognostic factors in order to maximize survival and neurologic function whilst avoiding unnecessary treatments. The goal of this article is to review important prognostic factors that may guide treatment selection, discuss the roles of surgery, radiation, and chemotherapy in the treatment of patients with brain metastases, and present new directions in brain metastasis therapy under active investigation. In the future, patients will benefit from a multidisciplinary approach focused on the integration of surgical, radiation, and chemotherapeutic options with the goal of prolonging survival, preserving neurologic and neurocognitive function, and maximizing quality of life.
转移性脑肿瘤是成人中最常见的颅内肿瘤。由于先进的成像方式、更早的检测以及对全身性疾病更有效的治疗,脑转移瘤的发病率似乎在上升。脑转移瘤的治疗方法包括手术、全脑放疗(WBRT)、立体定向放射外科治疗(SRS)和化疗。治疗决策必须考虑临床预后因素,以便在避免不必要治疗的同时,最大限度地提高生存率和神经功能。本文的目的是回顾可能指导治疗选择的重要预后因素,讨论手术、放疗和化疗在脑转移瘤患者治疗中的作用,并介绍正在积极研究的脑转移瘤治疗的新方向。未来,患者将受益于多学科方法,该方法侧重于整合手术、放疗和化疗方案,目标是延长生存期、保留神经和神经认知功能并最大限度地提高生活质量。